<DOC>
	<DOCNO>NCT02812966</DOCNO>
	<brief_summary>Investigators hypothesize patient present significant peripheral arterial disease clinical indication treatment angioplasty , difference 12 month patency subject Lutonix 035 Drug coat Balloon PTA Catheter IN.PACT Admiral Paclitaxel-Coated PTA Balloon Catheter .</brief_summary>
	<brief_title>Lutonix Inpact tHE tReatment Of fEmeropopliteal Stenosis - DCB</brief_title>
	<detailed_description>Investigators hypothesize patient present significant peripheral arterial disease clinical indication treatment angioplasty , difference 12 month patency ( define PSVR &lt; =2.4 12month follow-up visit TLR target lesion bypass ) subject Lutonix 035 Drug coat Balloon PTA Catheter IN.PACT Admiral Paclitaxel-Coated PTA Balloon Catheter . Investigators also assess compare target lesion revascularization rate , safety profile , adverse event , healthcare cost , healthcare utilization .</detailed_description>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<criteria>1 . Patient willing able provide inform consent , willing agrees comply regular follow visit , test , medication regimen compliance another treatment deem necessary treatment vascular disease . 2 . Male nonpregnant female 3 . Age great &gt; =18 year age 4 . Patients moderate severe claudication ischemic rest pain define Rutherford 24 class symptom 5 . &gt; =1 tibial runoff vessel baseline 6 . Angiographic criterion &gt; =70 % stenosis ( via visual angiographic estimate superficial femoral artery and/or popliteal artery appropriate ) 47mm vessel diameter &lt; =15cm plan treatment segment length . Planned treatment segment proximal 1 cm bifurcation common femoral artery distal 1 cm tibioperoneal trunk . Lesions treat within target vessel either De Novo lesions previously stented restenotic segment superficial femoral artery and/or popliteal artery great 90 day prior angioplasty procedure If target vessel previously stented treated lesion must least 3 cm previously place stent Lesion must able treat either drug coat balloon device base sizes specification device Successful , uncomplicated crossing must possible within treated lesion either without cross device Inflow artery must free significant occlusive disease ( &lt; 50 % ) confirm visual estimation angiography otherwise inflow artery must treat beforehand . At least 1 patent vessel outflow target vessel treat must present angiography 1 . Unable meet clinical criterion peripheral angioplasty followup treatment ( lab value pregnancy test ) 2 . Contraindicated either DCB 3 . &lt; 18 year age time consent and/or index procedure 4 . Pregnant Breast feeding 5 . Instent restenosis within target lesion 6 . Previously stented target lesion/vessel . 7 . Target lesion/vessel previously treat drugcoated balloon &lt; 12 month prior randomization/enrollment . 8 . Perforated vessel evidence extravasation contrast medium prior consent enrollment . 9 . Presence hemodynamically significant outflow lesion target limb require intervention &lt; =30 day consent randomization . 10 . Presence aneurysm target vessel . 11 . Major amputation target limb . 12 . Subjects undergone prior surgery SFA/PPA target limb treat atherosclerotic disease . 13 . Use atherectomy , laser debulking device target limb SFA/PPA index procedure . 14 . Acute ischemia and/or acute thrombosis SFA/PPA prior consent randomization . 15 . Known hypersensitivity contraindication contrast dye , opinion local investigator , adequately premedicated . 16 . Known hypersensitivity/allergy investigational stent system protocol related therapy . 17 . On dialysis immunosuppressant therapy . 18 . Concomitant renal failure ( include serum creatinine &gt; 2.0 mg/dL . ) 19 . Occurrence myocardial infarction ( MI ) cerebrovascular accident ( CVA ) &lt; =6 month prior consent . 20 . Platelet count &lt; 80,000 mm3 &gt; 600,000 mm3 history bleed diathesis . 21 . Unstable angina pectoris time consent randomization . 22 . Septicemia time consent randomization . 23 . Moderate severely calcify lesion .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>peripheral arterial disease</keyword>
	<keyword>drug coat balloon</keyword>
</DOC>